Cagrilintide is an experimental weight-loss medication that mimics the action of the hormone amylin, which is involved in regulating appetite and food intake. By slowing gastric emptying and promoting a feeling of fullness, it helps reduce calorie intake. Cagrilintide is often explored in combination with other medications, such as semaglutide, to enhance weight loss in individuals with obesity or related conditions. Its benefits include significant weight reduction and improved control over eating habits, making it a promising treatment for obesity management.